| Heading: |
Blood Transfusion Services: Innovation |
| Question ID: |
1786301 |
| UIN: |
39559 |
| House: |
Commons |
| Date tabled: |
2025-03-19 |
| Asking Member ID: |
4671 |
| Asking Member display name: |
Afzal Khan
|
| Asking Member handle: |
AfzalKhanMCR
|
| Asking Member Twitter reference: |
@AfzalKhanMCR
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to invest in new technologies and innovations to enhance the efficiency and resilience of the UK’s blood supply chain. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-03-28 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
NHS Blood and Transplant (NHSBT) is responsible for blood services in England. The baseline price charged by NHSBT to hospitals for the blood they use is negotiated annually between NHSBT, NHS England, and the Department. This reflects the investments tha... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |